UK first European nation to join Covid-19 High Performance Computing Consortium

June 03, 2020 //By Nick Flaherty
ARCHER at the University of Edinburgh will be part of the UK Research and Innovation (UKRI) has joined the US Covid-19 high performance computing (HPC) consortium
Three supercomputer centres in the UK will be part of the US Covid-19 high performance computing HPC consortium, the first European nation to join

The UK government is claiming to be the first European nation to join the US Covid-19 high performance computing HPC consortium.

The consortium of 40 companies and research institutes is sharing supercomputing resources to tackle the Covid-19 outbreak. There are currently has 56 active projects using more than 430 Petaflops of computing power.

The UK has added more than 20 Petaflops of high-performance computing capability from three supercomputers through UK Research and Innovation (UKRI). These include the ARCHER supercomputer at the University of Edinburgh, based around the Cray XC30, the DiRAC and the Hartree Centre at Daresbury Laboratory as well as the Biotechnology and Biological Sciences Research Council’s (BBSRC) Earlham Institute. The Met Office and UK Atomic Energy Authority will also provide capabilities to the consortium.

While UKRI says it is the first European supercomputing partner to join, there are three UK projects already using supercomputing capabilities through the Consortium. One, running on another Consortium supercomputer, is London-based machine-learning chemistry startup PostEra. This has already identified around 21 molecular designs that effectively target a key protein associated with Covid-19. Another project by AI startup Kuano in London looks to design a new drug.

Projects seeking access to UK facilities will be subject to peer review process to access project needs.  UKRI has a rolling urgent call for research proposals that address Covid-19 and proposals and the Consortium will cooperate with academics to use the appropriate facilities.

IBM researchers who are located at and working closely with the Hartree Centre, are collaborating with researchers at the University of Oxford where they are combining advanced molecular simulations with AI in a bid to discover new potential compounds that could be repurposed as candidate antiviral drugs for Covid-19.

“Tackling coronavirus requires a joint and strong international effort and the very best minds in science and technology sharing their research and knowledge,” said Amanda Solloway, UK Science Minister. “By joining this consortium, our leading researchers will be able to access some

Vous êtes certain ?

Si vous désactivez les cookies, vous ne pouvez plus naviguer sur le site.

Vous allez être rediriger vers Google.